Jichao Wei

676 total citations
22 papers, 557 citations indexed

About

Jichao Wei is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Jichao Wei has authored 22 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in Jichao Wei's work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), MicroRNA in disease regulation (3 papers) and FOXO transcription factor regulation (3 papers). Jichao Wei is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), MicroRNA in disease regulation (3 papers) and FOXO transcription factor regulation (3 papers). Jichao Wei collaborates with scholars based in China and United States. Jichao Wei's co-authors include Fandi Meng, Kai Qu, Kai Qu, Qifei Wu, Ming‐Hui Tai, Xinsen Xu, Hulin Chang, Zhixin Wang, Chang Liu and Qing Pang and has published in prestigious journals such as Scientific Reports, Energy and Cancer Letters.

In The Last Decade

Jichao Wei

22 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jichao Wei China 12 300 179 121 75 65 22 557
Vera P. Leoni Italy 17 472 1.6× 165 0.9× 88 0.7× 46 0.6× 67 1.0× 30 723
Boshi Sun China 13 349 1.2× 152 0.8× 138 1.1× 95 1.3× 61 0.9× 24 674
Jianjie Qin China 15 400 1.3× 268 1.5× 78 0.6× 110 1.5× 39 0.6× 21 695
Jiangning Gu China 13 269 0.9× 158 0.9× 158 1.3× 62 0.8× 75 1.2× 29 515
Zhihua Yang China 14 241 0.8× 106 0.6× 134 1.1× 45 0.6× 58 0.9× 34 521
Hamid Fiuji Iran 17 419 1.4× 248 1.4× 218 1.8× 46 0.6× 87 1.3× 44 686

Countries citing papers authored by Jichao Wei

Since Specialization
Citations

This map shows the geographic impact of Jichao Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jichao Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jichao Wei more than expected).

Fields of papers citing papers by Jichao Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jichao Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jichao Wei. The network helps show where Jichao Wei may publish in the future.

Co-authorship network of co-authors of Jichao Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Jichao Wei. A scholar is included among the top collaborators of Jichao Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jichao Wei. Jichao Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ruikun, Yukun Wu, Jiandong Jia, et al.. (2025). Design and operational performance evaluation of an integrated hydrothermal carbonization waste heat recovery and solar energy collection system. Energy. 321. 135472–135472. 3 indexed citations
2.
Sun, Na, et al.. (2023). Gallstones, cholecystectomy and the risk of pancreatic cancer: an updated systematic review and meta-analysis of cohort studies. European Journal of Gastroenterology & Hepatology. 35(12). 1313–1323. 6 indexed citations
3.
Li, Xin, Bin Chen, Jiang Yu, et al.. (2019). Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy. Digestive Diseases and Sciences. 64(11). 3215–3227. 29 indexed citations
4.
Qu, Kai, Xing Zhang, Ting Lin, et al.. (2017). Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation. Scientific Reports. 7(1). 1692–1692. 87 indexed citations
5.
Wei, Jichao, Fandi Meng, Kai Qu, et al.. (2015). Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1. Acta Pharmacologica Sinica. 36(2). 241–251. 82 indexed citations
6.
Qu, Kai, Ting Lin, Zhixin Wang, et al.. (2014). Reactive oxygen species generation is essential for cisplatininduced accelerated senescence in hepatocellular carcinoma. Frontiers of Medicine. 8(2). 227–235. 37 indexed citations
7.
Zhou, Lei, Xuejun Sun, Chang Liu, et al.. (2014). Overexpression of PSF1 is correlated with poor prognosis in hepatocellular carcinoma patients. The International Journal of Biological Markers. 30(1). 56–64. 16 indexed citations
8.
Tao, Jie, Xinsen Xu, Kai Qu, et al.. (2014). Down-regulation of FoxM1 inhibits viability and invasion of gallbladder carcinoma cells, partially dependent on inducement of cellular senescence. World Journal of Gastroenterology. 20(28). 9497–9505. 9 indexed citations
9.
Zhang, Lingqiang, Jia Xu, Yong Wan, et al.. (2013). Potential Therapeutic Targets for the Primary Gallbladder Carcinoma: Estrogen Receptors. Asian Pacific Journal of Cancer Prevention. 14(4). 2185–2190. 10 indexed citations
10.
Tian, Feng, Chang Liu, Qifei Wu, et al.. (2013). Upregulation of Glycoprotein Nonmetastatic B by Colony-Stimulating Factor-1 and Epithelial Cell Adhesion Molecule in Hepatocellular Carcinoma Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 20(8). 341–350. 17 indexed citations
11.
Qu, Kai, Xinsen Xu, Haibo Su, et al.. (2013). Emodin induces human T cell apoptosis in vitro by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction. Acta Pharmacologica Sinica. 34(9). 1217–1228. 86 indexed citations
12.
Zhou, Lei, et al.. (2013). Dubin-Johnson syndrome with cholecystolithiasis and choledocholithiasis. International Journal of Surgery Case Reports. 4(7). 587–588. 2 indexed citations
13.
Qu, Kai, Ting Lin, Jichao Wei, et al.. (2013). Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells.. PubMed. 33(9). 1253–9. 32 indexed citations
14.
Zhou, Lei, Chang Liu, Fandi Meng, et al.. (2012). Long-term Prognosis in Hepatocellular Carcinoma Patients after Hepatectomy. Asian Pacific Journal of Cancer Prevention. 13(2). 483–486. 14 indexed citations
15.
Xu, Jia, Chang Liu, Lei Zhou, et al.. (2012). Distinctions Between Clinicopathological Factors and Prognosis of Alpha-fetoprotein Negative and Positive Hepatocelluar Carcinoma Patients. Asian Pacific Journal of Cancer Prevention. 13(2). 559–562. 26 indexed citations
16.
Zhou, Lei, Chang Liu, Ji‐Gang Bai, et al.. (2012). A rare giant gastrointestinal stromal tumor of the stomach traversing the upper abdomen: a case report and literature review. World Journal of Surgical Oncology. 10(1). 66–66. 12 indexed citations
17.
Qu, Kai, Hulin Chang, Sinan Liu, et al.. (2012). Prognosis and Management for Gallbladder Cancer with Hepatic Invasion: Long-term Results of 139 Patients from a Single Center in China. Asian Pacific Journal of Cancer Prevention. 13(3). 1015–1018. 8 indexed citations
18.
Qu, Kai, Xinsen Xu, Chang Liu, et al.. (2012). Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma. Cancer Letters. 331(1). 105–114. 61 indexed citations
19.
Qu, Kai, Sinan Liu, Hulin Chang, et al.. (2012). Gallbladder Cancer: a Subtype of Biliary Tract Cancer Which is a Current Challenge in China. Asian Pacific Journal of Cancer Prevention. 13(4). 1317–1320. 10 indexed citations
20.
Zhou, Lei, Fandi Meng, Qifei Wu, et al.. (2011). Exploration on Surgical-Related Factors Influencing HCC Patients Prognosis. Hepatogastroenterology. 59(117). 1541–3. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026